Animals, Agriculture & Food

H3 Equine Influenza A Virus
WARF: P05092US
Inventors: Christopher Olsen, Gabriele Landolt, Alexander Karasin
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in an isolated H3 equine influenza A virus that could be used for vaccine development.
Overview
Influenza is a major respiratory disorder that affects humans and many animals, including horses. New strains of influenza arise frequently, creating a continuous need to isolate new influenza viruses for vaccine production.
The Invention
UW-Madison researchers have developed an isolated H3 equine influenza A virus, as well as methods of preparing and using the virus. This virus, which was isolated following a May 2003 outbreak of respiratory disease in horses, represents a new line of equine influenza virus. It is genetically related to a virus that caused an outbreak of influenza among horses in South Africa and to a virus isolated from greyhound dogs in Florida. This virus will be useful as part of an up-to-date vaccine against equine influenza.
Applications
- Equine influenza vaccines
Key Benefits
- Provides a potential new influenza strain for equine and possibly canine vaccine development
Additional Information
For More Information About the Inventors
Related Intellectual Property
For current licensing status, please contact Emily Bauer at [javascript protected email address] or 608-960-9842
- View Divisional Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.